Chronic obstructive respiratory diseases – european commission

The objective of the Community action in the field of public health (2003-2008) is to evaluate the impact on COPD prevalence of possible health policy interventions. Some countries in europe These interventions should also focus on the reduction of specific COPD risk factors. Countries in europe For this purpose the European Commission supports, on the framework of the Community action in the field of public health, the EU project IMCA (Indicators for Monitoring COPD and asthma in the EU) to develop indicators to monitor asthma and COPD in the European Union, to describe the prevalence of COPD related symptoms, asthma at tacks, physician diagnosed COPD by age group, gender, socioeconomic status and geographical area and to monitor changes over time on the indicators proposed. How many countries in europe speak english The general objective of the IMCA project was to get a consensus among the project participants on a set of indicators for monitoring the prevalence, risk factors, clinical management and outcomes of COPD in the EU. List of countries in europe union Taking this list as starting point and according to the methodology approved by the Steering Committee and the IMCA group, the coordinating centre has further developed the list creating the “Initial matrix of indicators for COPD”. Name 5 countries in europe This matrix, organized the indicators selected according to the framework already established by the European Community Health Indicators (ECHI) project, which is the main framework, supported and required by DG Health and Consumer Protection.

The number of epidemiological studies which have assessed the prevalence of COPD is still limited. How many countries in europe union Information on the prevalence of COPD can be obtained from two main sources of data: 1) general health interview or examination surveys and 2) research studies. How many countries are in eastern europe However, the quality of the information is very poor and limited in general health interview surveys and the information provided from research studies is difficult to compare. How many countries are in europe The data quality mainly depends on the methods used in each specific study. Four countries in europe However, the most relevant problems seems to be the difficulties in comparing results between studies due to the lack of consensus on the methods and definitions.

Thirty-two sources of COPD prevalence rates, representing 17 countries and eight World Health Organization-classified regions, were identified and reviewed by Hallbert et al. What countries are in europe Prevalence estimates were based on spirometry (11 studies), respiratory symptoms (14 studies), patient-reported disease (10 studies), or expert opinion. List of richest countries in europe Reported prevalence ranged from 0.23 to 18.3%. Countries located in europe The lowest prevalence rates (0.2 to 2.5%) were based on expert opinion. List of countries in northern europe Sixteen studies had measured rates that could reasonably be extrapolated to an entire region or country. 15 countries in europe All were for Europe or North America, and most fell between 4% and 10%. List of developing countries in europe There is considerable variation in the reported prevalence of COPD. Which are the countries in europe The overall prevalence in adults appears to lie between 4% and 10% in countries where it has been rigorously measured. B countries in europe Some of the variation attributed to differences in risk exposure or population characteristics may be influenced by the methods and definitions used to measure disease. Which countries are in europe Spirometry is least influenced by local diagnostic practice, but it is subject to variation based on the lung function parameters selected to define COPD.

The international study “The Confronting COPD International Survey” aimed to quantify morbidity and burden in COPD subjects in 2000. How much countries are in europe From a total of 201 921 households screened by random-digit dialling in the USA, Canada, France, Italy, Germany, The Netherlands, Spain and the UK, 3 265 subjects with a diagnosis of COPD, chronic bronchitis or emphysema, or with symptoms of chronic bronchitis, were identified. List of socialist countries in europe The mean age of the subjects was 63.3 yrs and 44.2% were female. How many countries in europe held colonial possessions in 1914 Subjects with COPD in North America and Europe appear to underestimate their morbidity, as shown by the high proportion of subjects with limitations to their basic daily life activities, frequent work loss (45.3% of COPD subjects of <65 yrs reported work loss in the past year) and frequent use of health services (13.8% of subjects required emergency care in the last year), and may be undertreated. Countries in europe population This international survey confirmed the great burden to society and high individual morbidity associated with chronic obstructive pulmonary disease in subjects in North America and Europe. Countries in europe by population The definition used in this study was: "Proportion of individuals aged ³45 years who had cumulative cigarette consumption of ³10 pack-years and who had been diagnosed with COPD, emphysema or chronic bronchitis, or whose symptoms fulfilled a definition of chronic bronchitis, i.e. What are countries in europe "persistent coughing with phleghm or sputum from the chest for the last 2 years or more".

In 1995, the European Respiratory Society published a European Consensus Statement on the optimal assessment and management of COPD. List of countries in european union In the document, several important areas for future research are identified that may help to increase knowledge of the current situation of COPD within Europe; these include pathophysiology, epidemiology, and the clinical benefits of treatment. Names of countries in europe and their capitals This article reviews a selection of important data that have become available since the consensus statement was published, with a specific focus on epidemiology and treatment.